EichorEICHOR
Condition: Severe Acute Respiratory Syndrome Coronavirus 2 Synced from ClinicalTrials.gov · August 06, 2026

Recruiting studies: Severe Acute Respiratory Syndrome Coronavirus 2

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Immune-mediated Pathogenic Mechanisms of Neuro-PASC in Veterans
Phase N/A · 2 location(s) · VA Office of Research and Development · NCT06932237A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broa
Phase 1/Phase 2 · 2 location(s) · Kara Chew · NCT06810934Study Evaluating the Impact of Using Triplex Rapid Diagnostic Tests (SARS-CoV-2/Influenza/RSV) on Antibiotic Prescribing
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07243249COVID-19 in PID Survey
Phase N/A · 1 location(s) · Imagine Institute · NCT04459689Vale+Tú Salud: Corner-Based Trial to Test a Latino Day Laborer Program Adapted to Prevent COVID-19
NA · 1 location(s) · The University of Texas Health Science Center, Houston · NCT06821113SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Phase N/A · 68 location(s) · Massive Bio, Inc. · NCT03452774Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise
Phase 2 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT04427566The Effects of Endotracheal Suctioning on Pain and Serum Markers
NA · 1 location(s) · Loma Linda University · NCT06692400Cross-Sectional Evaluation of Persistence of SARS-CoV-2 Remnants After Recovery From Acute Infection
Phase N/A · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT06577467Serological and PCR Testing for COVID-19
Phase N/A · 1 location(s) · Richmond Research Institute · NCT04404062Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute
Phase 1/Phase 2 · 3 location(s) · PEACHES BIOTECH · NCT06684379Does Taurine Supplementation Improve Vascular Function and Orthostatic Responses in Long COVID?
Phase N/A · 1 location(s) · York University · NCT07312409Longterm Influence of Pediatric Long COVID Syndrome
Phase N/A · 1 location(s) · National Taiwan University Hospital · NCT05566392Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS
Phase 2 · 1 location(s) · Vanderbilt University Medical Center · NCT07189936Osteopathic Manipulative Therapy Effects on Post-Acute Sequelae of COVID-19 (PASC) or Long COVID
NA · 1 location(s) · University of Louisville · NCT06883513Impact of Post-ARDS Covid-19 Sedation on Persistent Neuroinflammation
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05233605Observational Study on Immunoadsorption (IA) in Patients With Autoantibody-Positive Post-Infectious ME/CFS
Phase N/A · 1 location(s) · Charite University, Berlin, Germany · NCT07529197PERCEIVE-Outreach: A Scalable, Risk-Based Model for Managing Persistent Cardiovascular Impact in Long COVID
NA · 2 location(s) · University of Tasmania · NCT07661862A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
Phase 1 · 12 location(s) · GlaxoSmithKline · NCT07464314Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Tianeptine in the Treatment of Covid Fo
Phase 2 · 1 location(s) · Military Institute od Medicine National Research Institute · NCT06012552Long-Covid-19 Alleviation Through Learning Mindfulness Study
NA · 1 location(s) · Columbia University · NCT07140094A Study to Assess Anktiva in Patients With Long Covid-19.
Phase 2 · 1 location(s) · ImmunityBio, Inc. · NCT07108036Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2
Phase N/A · 1 location(s) · Washington University School of Medicine · NCT06848309Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Sym
Phase 3 · 17 location(s) · Wes Ely · NCT06631287ACT for Mental Health in Neurological Disorders
NA · 1 location(s) · Bielefeld University · NCT06897553Acupuncture and Chinese Herbal Medicine for Long COVID
NA · 1 location(s) · Southern California University of Health Sciences · NCT07285707Living With Primary Ciliary Dyskinesia (Living With PCD)
Phase N/A · 1 location(s) · University of Bern · NCT04602481The Long COVID-19 Wearable Device Study
NA · 1 location(s) · Scripps Translational Science Institute · NCT05741112Predictors of Post-COVID-19 Clinical and Cognitive Consequences
Phase N/A · 1 location(s) · VA Office of Research and Development · NCT06291870Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection
Phase N/A · 1 location(s) · Consorci Sanitari de Terrassa · NCT04367883
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.